FDA-approved · Cash-pay · Ships to your door
Mounjaro®
FDA-approved tirzepatide from Eli Lilly, prescribed online by a US-licensed clinician when clinically appropriate. Cash-pay; not billed to insurance.
Medication, if prescribed
Mounjaro®
$1,349/mo
Cash-pay; not billed to insurance
If a clinician decides treatment isn't right for you, you're refunded in full.
Mounjaro® is the FDA-approved product from Eli Lilly and Company, dispensed cash-pay through a US-licensed pharmacy. Pricing reflects pharmacy cash-pay rates and may change. A prescription is at the discretion of a US-licensed clinician.
- FDA-approved tirzepatide for type 2 diabetes
- Once-weekly dual GIP / GLP-1 subcutaneous injection
- Reviewed online and shipped from a US-licensed pharmacy
- Flat cash-pay pricing — no insurance billing
Mounjaro® is the FDA-approved tirzepatide product from Eli Lilly and Company, indicated for type 2 diabetes mellitus to improve glycemic control alongside diet and exercise. It is sometimes prescribed off-label for weight management at the discretion of a licensed clinician when clinically indicated.
The easiest way to find out is to start. Our US-licensed provider partners review a short online intake — usually just a few minutes — and determine what's right for you on an individual basis, based on your health history and goals. There's no cost to find out and no obligation.
Yes. Shipping is always free, and every order arrives in plain, unmarked packaging from a US-licensed pharmacy — no one needs to know what's inside. Most orders arrive within about a week of approval.
Yes. Pallas is a cash-pay medical service, and we provide an itemized receipt for your visit and prescription that you can submit to your FSA or HSA. Most plans treat prescription medications and telehealth visits as eligible expenses — your plan administrator can confirm what applies to you.
About
What is Mounjaro®?
Mounjaro® is the FDA-approved tirzepatide product from Eli Lilly and Company, indicated for type 2 diabetes mellitus to improve glycemic control alongside diet and exercise. It is sometimes prescribed off-label for weight management at the discretion of a licensed clinician when clinically indicated.
Pallas dispenses Mounjaro® through US-licensed pharmacies on a cash-pay basis. Insurance routing is not currently supported. Eligibility is determined by a licensed clinician based on your intake and clinical history.
Pivotal trial · SURPASS program
In the SURPASS clinical program, tirzepatide demonstrated significant HbA1c reductions across a range of T2D populations.
Source: Eli Lilly SURPASS trial program. Outcome reflects the cited trial of the FDA-approved product and the conditions studied. Individual results may differ.
Dosing
Dosing & schedule
Mounjaro® uses a dose-escalation schedule. Your clinician determines the right starting dose and pace of escalation based on your indication and tolerability.
- Weeks 1–42.5 mg once weekly — starting dose (non-therapeutic, for tolerability)
- Weeks 5–85 mg once weekly
- Weeks 9+Increased every 4 weeks as tolerated, up to 15 mg weekly maintenance
Safety
Important safety information
GLP-1 medications can cause nausea, vomiting, diarrhea, constipation, and abdominal discomfort, particularly during dose increases. Rare but serious risks include pancreatitis, gallbladder disease, kidney injury from dehydration, and — based on animal studies — a possible risk of thyroid C-cell tumors. Patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use these medications. Always disclose your full medical history to your clinician.
FAQ
Common questions
The easiest way to find out is to start. Our US-licensed provider partners review a short online intake — usually just a few minutes — and determine what's right for you on an individual basis, based on your health history and goals. There's no cost to find out and no obligation.
Yes. Shipping is always free, and every order arrives in plain, unmarked packaging from a US-licensed pharmacy — no one needs to know what's inside. Most orders arrive within about a week of approval.
Yes. Pallas is a cash-pay medical service, and we provide an itemized receipt for your visit and prescription that you can submit to your FSA or HSA. Most plans treat prescription medications and telehealth visits as eligible expenses — your plan administrator can confirm what applies to you.
We'll make it right. Pallas includes unlimited customer support — if anything's off with your shipment, or you simply have a question about your treatment, our support team and your care team are a message away, as often as you need, at no extra cost.
Pallas is cash-pay and doesn't bill insurance directly — that keeps your pricing simple and predictable. But because you receive the genuine, FDA-approved product with an itemized receipt, some patients choose to submit a claim to their insurer afterward for possible out-of-network reimbursement. Whether it's reimbursed is up to your individual plan.
Mounjaro® is the brand name for FDA-approved tirzepatide manufactured by Eli Lilly for type 2 diabetes. Tirzepatide activates both the GIP and GLP-1 receptors, delivered as a once-weekly subcutaneous injection.
Mounjaro® is FDA-approved for type 2 diabetes, and a US-licensed clinician may prescribe it off-label for weight management when it's clinically appropriate for you. If weight is your main goal, your provider can also walk you through Zepbound® — the tirzepatide product from the same manufacturer that's FDA-approved specifically for chronic weight management.
Mounjaro® is $1,349/month on Pallas, billed flat with no insurance routing. The price covers a 28-day supply shipped directly from a US-licensed pharmacy.
Yes — no contracts and no lock-in. You can pause or cancel your plan anytime, right from your patient portal.
Disclosures
Mounjaro® is a registered trademark of Eli Lilly and Company. The trademark owner is not affiliated with, a sponsor of, or an endorser of Pallas. Pallas dispenses the FDA-approved product cash-pay through a US-licensed pharmacy network; it is not billed to insurance. Eligibility and any prescription are determined by a US-licensed clinician.
Start your visit